Skip to main content

NHGRI Adds IP-Management Guidelines to Genome Sequencing Center RFA

NEW YORK, March 27 (GenomeWeb News) - The National Human Genome Research Institute has amended a large-scale sequencing RFA that it issued in December to include guidelines for intellectual property related to the initiative.

 

In a notice issued Friday, NHGRI updated its previous "Genome Sequencing Centers" request for applications to include the stipulation that awardees manage IP and data in a way that will "maximize the public benefit of the data produced."

 

As a result, "applicants should develop a comprehensive IP and data management strategy that is consistent with the NIH Research Tools Policy," NIH said.

 

"Applicants should submit an IP Management Plan that assures that data is rapidly released according to approved criteria, that licensing and sharing practices ensure the availability of data and research resources for future use by the scientific community, and that research collaboration or sponsorship agreements are consistent with the requirements of the TCGA [The Cancer Genome Atlas] and the NHGRI medical sequencing program," NIH said in the notice.

 

Further details are available here.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.